SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Meury William

(Last)

(First)

(Middle)

CLONSHAUGH BUSINESS AND TECHNOLOGY PARK,

COOLOCK, CO.

(Street)

DUBLIN

D17 E400

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Allergan plc [ AGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Commercial Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/14/2018

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Ordinary Shares, par value $0.0001	02/14/2018		M		1,957	A	$51.07	56,944⁽¹⁾⁽²⁾	D
Ordinary Shares, par value $0.0001	02/14/2018		M		2,765	A	$51.07	59,709⁽²⁾	D
Ordinary Shares, par value $0.0001	02/14/2018		M		1,510	A	$66.2	61,219⁽²⁾	D
Ordinary Shares, par value $0.0001	02/14/2018		M		17,381	A	$66.2	78,600⁽²⁾	D
Ordinary Shares, par value $0.0001	02/14/2018		S		25,079	D	$157.18⁽³⁾	53,521⁽²⁾	D
Ordinary Shares, par value $0.0001	02/14/2018		S		1,200	D	$157.6⁽⁴⁾	52,321⁽²⁾	D
Ordinary Shares, par vaule $0.0001	02/14/2018		S		1,700	D	$158.78⁽⁵⁾	50,621⁽²⁾	D
Ordinary Shares, par value $0.0001	02/14/2018		S		2,400	D	$159.82⁽⁶⁾	48,221⁽²⁾	D
Ordinary Shares, par vaule $0.0001	02/14/2018		S		1,000	D	$161.1⁽⁷⁾	47,221⁽²⁾	D
Ordinary Shares, par value $0.0001	02/14/2018		S		4,700	D	$162.22⁽⁸⁾	42,521⁽²⁾	D
Ordinary Shares, par value $0.0001	02/14/2018		S		7,200	D	$163.04⁽⁹⁾	35,321⁽²⁾	D
Ordinary Shares, par value $0.0001	02/14/2018		S		2,000	D	$164.62⁽¹⁰⁾	33,321⁽²⁾	D
Ordinary Shares, par value $0.0001	02/14/2018		S		13,600	D	$165.16⁽¹¹⁾	19,721⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Incentive Stock Option	$51.07	02/14/2018		M			1,957	⁽¹²⁾	12/07/2018	Ordinary Shares	1,957	$0	0	D
Non-Qualified Options to Purchase Common Stock	$51.07	02/14/2018		M			2,765	⁽¹³⁾	12/07/2018	Ordinary Shares	2,765	$0	0	D
Incentive Stock Option	$66.2	02/14/2018		M			1,510	⁽¹⁴⁾	12/06/2019	Ordinary Shares	1,510	$0	0	D
Non-Qualified Options to Purchase Common Stock	$66.2	02/14/2018		M			17,381	⁽¹⁵⁾	12/06/2019	Ordinary Shares	17,381	$0	0	D

Explanation of Responses:

1. The total number of shares reported has been reduced by 423 due to prior inadvertent over-reporting of shares beneficially owned by the Reporting Person.

2. Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc.

3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $156.29 to $157.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $157.30 to $158.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $158.30 to $159.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

6. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $159.41 to $160.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

7. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $160.59 to $161.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

8. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $161.67 to $162.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

9. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $162.68 to $163.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

10. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $164.04 to $165.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

11. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $165.05 to $165.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

12. The option vested on December 8, 2013.

13. The option vested in five equal installments on December 8, 2009, 2010, 2011, 2012 and 2013.

14. The option vested on December 7, 2014.

15. The option vested in five equal installments on December 7, 2010, 2011, 2012, 2013 and 2014.

	/s/ A. Robert D. Bailey, Attorney-in-Fact for the Reporting Person	02/16/2018
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.